Psychiatric Disorders Treated

Novel Treatment for Depression

One third of patients with Major Depressive Disorder experience treatment-resistant depression (TRD) and do not achieve full remission despite multiple adequate trials of antidepressant treatment (McIntyre et al., 2014; Trevino

N-methyl-d-aspartate (NMDA) receptor antagonist, has recently emerged as a safe and effective novel treatment for people with TRD with rapid antidepressant effects et al., 2014).

Cognitive impairment is more common in people with TRD (Lopez-Sola et al., 2020), and is associated with poorer social and occupational functioning and quality of life (Cambridge et al., 2018;

RMC delivers the KAP treatment intervention for Treatment Resistant Depression in 

select Clinic rooms of selected Clinical Psychologists (with Doctorates in Psychology) in ACT.

The intervention is delivered by the Psychiatrist, Clinical Psychologist and Registered Nurse.

RMC undertakes this treatment with strict medical and nursing policies and procedures and medical equipment onsite along with a Registered Nurse present.

Typically the number of sessions is between 6 and 8.
The treatment has different methods of transmission .

Guidelines & Regulatory Frameworks

All treatment pathways strictly follow :

The Black Dog KSET measurement-based safety monitoring system which capture acute, cumulative and longer term side effects.

The Royal Australian College of Psychiatrists 

Clinical Practice Guidelines for Mood Disorders.

Australian & New Zealand Journal of Psychiatry

2021, Vol. 55(1) 7–117.

© The Royal Australian and

New Zealand College of Psychiatrists

The Royal Australian College of Psychiatrists Professional Practice Guideline 4 

PPG 4 PPP ‘Off-label’ prescribing in psychiatry.

© The Royal Australian and

New Zealand College of Psychiatrists

RANZCP Clinical Memorandum CLM PPR (July 2022) is followed for the psychiatric treatment pathway 

for Treatment Resistant Depression

RMC uses Canberra Script and Safe Script NSW

Dr Lewis is an authorised prescriber of Schedule 8 *Medication as listed in The Medicines, Poisons & Therapeutic Goods Act 2008.

This pathway uses a medical model embracing Novel Therapies and administration of a Schedule 8 *Medication over 6 or 8 sessions. 

Resources on Borderline Personality Disorder 

• Calm - One of the most popular apps for sleep, meditation and relaxation, Calm provides breathing programs, meditation sessions, music and sounds to help you relax.
• Smiling Mind - An Australian app and developed by psychologists and educators, Smiling Mind offers a range of programs for children, teens and adults. It focuses on mindfulness, but also has programs related to exercise, the workplace and social interactions.
• Headspace - Headspace focuses on mindfulness and meditation and delivers a range of themes and topics to aid you reduce stress and improve focus.
• Way of Life - Way of Life aids with behaviour change, aiming to motivate you to build a better, stronger and healthier.